[go: up one dir, main page]

AU2002335963A1 - Protein biopolymer markers predictive of alzheimers disease - Google Patents

Protein biopolymer markers predictive of alzheimers disease

Info

Publication number
AU2002335963A1
AU2002335963A1 AU2002335963A AU2002335963A AU2002335963A1 AU 2002335963 A1 AU2002335963 A1 AU 2002335963A1 AU 2002335963 A AU2002335963 A AU 2002335963A AU 2002335963 A AU2002335963 A AU 2002335963A AU 2002335963 A1 AU2002335963 A1 AU 2002335963A1
Authority
AU
Australia
Prior art keywords
alzheimers disease
biopolymer markers
markers predictive
protein biopolymer
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002335963A
Inventor
George Jackowski
John Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syn X Pharma Inc
Original Assignee
Syn X Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn X Pharma Inc filed Critical Syn X Pharma Inc
Publication of AU2002335963A1 publication Critical patent/AU2002335963A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002335963A 2001-11-23 2002-10-31 Protein biopolymer markers predictive of alzheimers disease Abandoned AU2002335963A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99329801A 2001-11-23 2001-11-23
US09/993,298 2001-11-23
PCT/CA2002/001639 WO2003046564A2 (en) 2001-11-23 2002-10-31 Protein biopolymer markers predictive of alzheimers disease

Publications (1)

Publication Number Publication Date
AU2002335963A1 true AU2002335963A1 (en) 2003-06-10

Family

ID=25539359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002335963A Abandoned AU2002335963A1 (en) 2001-11-23 2002-10-31 Protein biopolymer markers predictive of alzheimers disease

Country Status (3)

Country Link
JP (1) JP2005510720A (en)
AU (1) AU2002335963A1 (en)
WO (1) WO2003046564A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668149A4 (en) * 2003-09-05 2007-01-03 Royal Women S Hospital MARKER FOR THE DIAGNOSIS OF OVARIAN CANCER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1117680A2 (en) * 1998-09-29 2001-07-25 Lars Christian B. Ronn Ncam binding compounds
FR2797402B1 (en) * 1999-07-15 2004-03-12 Biomerieux Stelhys USE OF A POLYPEPTIDE FOR DETECTING, PREVENTING OR TREATING A CONDITION ASSOCIATED WITH A DEGENERATIVE, NEUROLOGICAL OR AUTOIMMUNE DISEASE
AU2001236589A1 (en) * 2000-02-04 2001-08-14 Aeomica, Inc. Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes

Also Published As

Publication number Publication date
WO2003046564A3 (en) 2004-02-19
JP2005510720A (en) 2005-04-21
WO2003046564A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
AU2002340641A1 (en) Methods for assembling protein microarrays
AU2002336843A1 (en) Biopolymer markers predictive of alzheimers disease
AUPR279101A0 (en) Protein kinase signalling
AU2003252072A1 (en) Modulation of protein kinase c-iota expression
AU2002335964A1 (en) Ig lambda biopolymer markers predictive of alzheimers disease
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2003282338A1 (en) Determination of protein function
AU2001288973A1 (en) Non-genetic based protein disease markers
AU2002335977A1 (en) Protein biopolymer markers predictive of insulin resistance
AU2002336844A1 (en) Protein biopolymer markers predictive of insulin resistance
AU2002335963A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002335969A1 (en) Complement c3 precursor biopolymer markers predictive of alzheimers disease
AU2002335967A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002335975A1 (en) Apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002336842A1 (en) Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335965A1 (en) Pedf biopolymer markers predictive of alzheimers disease
AU2002249453A1 (en) Enzyme and snp marker for disease
AU2002335972A1 (en) Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335971A1 (en) Fibronectin precursor biopolymer marker predictive of alzheimers disease
AU2002336018A1 (en) Protein biopolymer markers predictive of type ii diabetes
AU2002335966A1 (en) Plasma protease c1 biopolymer markers predictive of alzheimers disease
AU2002254298A1 (en) High accuracy protein identification
AU2002335968A1 (en) Protein biopolymer markers indicative of a disease state
AU2003226441A1 (en) Methods of identifying putative effector proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase